Total Payments
$173,525
2021 Payments
$13,525
Companies
2
Transactions
18
Medicare Patients
4,742
Medicare Billing
$1.4M
Payment Breakdown by Category
Consulting$163,525 (94.2%)
Food & Beverage$10,000 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $163,525 | 17 | 94.2% |
| Food and Beverage | $10,000 | 1 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Validus Pharmaceuticals LLC | $170,000 | 17 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $3,525 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $13,525 | 2 | Validus Pharmaceuticals LLC ($10,000) |
| 2020 | $40,000 | 4 | Validus Pharmaceuticals LLC ($40,000) |
| 2019 | $40,000 | 4 | Validus Pharmaceuticals LLC ($40,000) |
| 2018 | $40,000 | 4 | Validus Pharmaceuticals LLC ($40,000) |
| 2017 | $40,000 | 4 | Validus Pharmaceuticals LLC ($40,000) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/31/2021 | Validus Pharmaceuticals LLC | Equetro (Drug) | Food and Beverage | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 01/15/2021 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $3,525.00 | General |
| Category: ONCOLOGY | ||||||
| 12/31/2020 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 09/30/2020 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 06/30/2020 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 03/31/2020 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 12/12/2019 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 09/30/2019 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 06/30/2019 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 03/31/2019 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 12/15/2018 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 10/01/2018 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 07/01/2018 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 03/31/2018 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 12/12/2017 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 09/30/2017 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 06/30/2017 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
| 03/31/2017 | Validus Pharmaceuticals LLC | Equetro (Drug) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,175 | 1,586 | $2.1M | $359,856 |
| 2022 | 19 | 1,204 | 1,644 | $2.0M | $374,303 |
| 2021 | 17 | 960 | 1,317 | $1.4M | $288,771 |
| 2020 | 21 | 1,403 | 1,869 | $2.2M | $413,203 |
Total Patients
4,742
Total Services
6,416
Medicare Billing
$1.4M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 240 | 306 | $1.0M | $169,695 | 16.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 119 | 167 | $339,010 | $60,333 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 266 | 409 | $104,295 | $31,191 | 29.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 49 | 56 | $173,320 | $28,930 | 16.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 157 | 157 | $62,015 | $14,806 | 23.9% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 31 | 44 | $23,320 | $13,485 | 57.8% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 31 | 40 | $41,400 | $7,722 | 18.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 47 | 50 | $75,750 | $7,140 | 9.4% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 16 | 20 | $37,600 | $6,957 | 18.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 73 | 91 | $44,590 | $5,784 | 13.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 28 | 30 | $46,800 | $4,624 | 9.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 23 | 28 | $20,720 | $2,415 | 11.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 18 | $16,110 | $2,201 | 13.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $16,920 | $1,776 | 10.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 22 | 30 | $12,450 | $1,166 | 9.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 14 | $3,710 | $622.44 | 16.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 98 | $5,880 | $579.46 | 9.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $2,480 | $431.31 | 17.4% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 243 | 325 | $1.0M | $178,956 | 17.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 129 | 210 | $400,310 | $76,548 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 220 | 296 | $75,480 | $23,058 | 30.5% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 37 | 44 | $129,530 | $22,320 | 17.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 29 | 46 | $23,225 | $14,193 | 61.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 146 | 146 | $57,670 | $13,798 | 23.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 80 | 109 | $50,605 | $7,775 | 15.4% |
About Dr. David Leffell, MD
Dr. David Leffell, MD is a Dermatology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518940410.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Leffell, MD has received a total of $173,525 in payments from pharmaceutical and medical device companies, with $13,525 received in 2021. These payments were reported across 18 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($163,525).
As a Medicare-enrolled provider, Leffell has provided services to 4,742 Medicare beneficiaries, totaling 6,416 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location New Haven, CT
- Active Since 11/23/2005
- Last Updated 02/13/2009
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518940410
Products in Payments
- Equetro (Drug) $170,000
- LIBTAYO (Biological) $3,525
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New Haven
Dr. Keith Choate, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $672,063
Dermatology $672,063
Richard Antaya, Md, MD
Dermatology — Payments: $73,754
Dermatology $73,754
Dr. Lisa Donofrio, M.d, M.D
Dermatology — Payments: $59,053
Dermatology $59,053
Dr. Jonathan Leventhal, M.d, M.D
Dermatology — Payments: $58,910
Dermatology $58,910
Peter Heald, Md, MD
Dermatology — Payments: $50,990
Dermatology $50,990
Mr. Mark Goldstein, Md, MD
Dermatology — Payments: $47,017
Dermatology $47,017